Company Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally.
The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities.
It also provides central pharmacy dispensing services; IV compounding services; turnkey solution designed to help health systems establish, manage, and optimize an entity-owned specialty pharmacy, as well as support onsite management of specialty pharmacy services, including payer contracting, staffing, licensing, and 340B program administration.
In addition, the company offers inventory optimization services comprising predictive and prescriptive analytics, benchmarking, workflow tools, and clinical resources, as well as medication inventory visibility; patient engagement, clinical, and financial solutions; medication adherence solutions, which include single-dose automation solutions, automated and semi-automated filling equipment, various medication blister card packaging and packaging supplies; and software that guides users through the manual filling process.
Further, it provides professional services, such as technology installation, program management, customer education and training, change management services, and related offerings; technical services comprising post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; and retail pharmacy and hospital automation outside the United States business.
The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001.
The company was incorporated in 1992 and is headquartered in Fort Worth, Texas.
| Country | United States |
| Founded | 1992 |
| IPO Date | Aug 7, 2001 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 3,670 |
| CEO | Randall Lipps |
Contact Details
Address: 4220 North Freeway, Suite 301 Fort Worth, Texas 76137 United States | |
| Phone | 877 415 9990 |
| Website | omnicell.com |
Stock Details
| Ticker Symbol | OMCL |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000926326 |
| CUSIP Number | 68213N109 |
| ISIN Number | US68213N1090 |
| Employer ID | 94-3166458 |
| SIC Code | 3571 |
Key Executives
| Name | Position |
|---|---|
| Randall A. Lipps | Founder, Executive Chairman, President and Chief Executive Officer |
| Nchacha E. Etta | Executive Vice President and Chief Financial Officer |
| Nnamdi N. Njoku | Executive Vice President and Chief Operating Officer |
| Corey J. Manley | Executive Vice President, Chief Legal and Administrative Officer and Corporate Secretary |
| Brian H. Nutt | Vice President, Chief Accounting Officer and Corporate Controller |
| Dr. Perry A. Genova Ph.D. | Senior Vice President and Chief Technology Officer |
| Giri Chodavarapu | Senior Vice President and Chief Information Officer |
| Kathleen Nemeth | Senior Vice President of Investor Relations |
| Maximo Rocha | Senior Vice President and Chief People Officer |
| Minoo Mortazavi | Senior Vice President of Global Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 18, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jun 5, 2025 | 8-K | Current Report |
| May 23, 2025 | 8-K | Current Report |
| May 22, 2025 | SD | Form - SD |
| May 22, 2025 | 8-K | Current Report |
| May 7, 2025 | 10-Q | Quarterly Report |
| May 6, 2025 | 8-K | Current Report |
| Apr 28, 2025 | SCHEDULE 13G/A | Filing |
| Apr 3, 2025 | ARS | Filing |
| Apr 3, 2025 | DEF 14A | Other definitive proxy statements |